CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CG Invites Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CG Invites Co Ltd
CG Invites R&D Center
38, Magokjungang 8-ro, Gangseo-gu
Phone: +82 221072700p:+82 221072700 SEOUL, 07802  South Korea Ticker: 083790083790
Business Summary
CG Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Research and Development segment is engaged in the research, development and sale of new drugs such as anti-inflammatory painkillers, anticancer drugs, anti-infectives and others. It is also engaged in the real estate rental business. The Pharmaceutical Manufacturing segment is engaged in the manufacture, retail and wholesale of finished drug products. The Other segment is engaged in the manufacture and sale of hot packs and other household items.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
3999 Manufacturing industries, not elsewhere classified
3634 Electric housewares and fans
6512 Operators of nonresidential buildings

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Co-Chief Executive Officer, Director Yin CheolJung 60 3/25/2024
Co-Chief Executive Officer, Director Su YeonOh 3/25/2024 3/25/2024
Internal Auditor Yeong JunYoo 67 12/20/2021 12/20/2021
5 additional Officers and Directors records available in full report.

Business Names
Business Name
083790
Crystal Genomics Inc.
Crystal Genomics, Inc.
CrystalGenomics, Inc.

General Information
Number of Employees: 64 (As of 12/31/2015)
Outstanding Shares: 76,543,443 (As of 12/31/2023)
Shareholders: 26,862
Stock Exchange: KDQ
Fax Number: +82 226592711


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024